[1] Retatrutide: What the Evidence Actually Shows Retatrutides pivotal obesity dataset is a Phase 2, double-blind, randomised, placebo-controlled trial in adults with obesity (or overweight plus a weight-related condition), testing once-weekly doses up to 12 mg over 48 weeks
For researchers studying the broader weight loss peptide landscape, our best peptides for weight loss guide covers compounds from every receptor class, and our AOD-9604 guide covers another non-appetite-based fat metabolism compound
Yan, Y., Zuo, X
Unadjusted and multivariate adjusted weighted Cox proportional risk regressions were used to assess the association between MMA, B12-related biomarkers (serum level, dietary intakes, supplements use, and sensitivity to B12), and the risk of mortality
What can I expect for results
However, patient experience is mixed: while some members report no difference between the two methods, others find they do not achieve the same symptom resolution with SC injections